AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33735206 — intervention group
Group type: COMPARATOR
Intervention: early-FTIC
Number of subjects: 693
Study 33735206 — intervention group
Group type: EXPERIMENTAL
Intervention: Not achieving composite outcome
Number of subjects: 693
Study 32382928 — intervention group
Group type: EXPERIMENTAL
Intervention: GuttaFlow Bioseal
Number of subjects: 48
Study 32382928 — intervention group
Group type: COMPARATOR
Intervention: BioRoot RCS
Number of subjects: 48
Study 36270095 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (20 mg once daily for five days)
Number of subjects: 65
Study 36270095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 33135866 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic-supplemented arm (two 4 oz. servings of the probiotic yogurt product daily)
Number of subjects: 20
Study 33135866 — intervention group
Group type: COMPARATOR
Intervention: Probiotic-restricted arm
Number of subjects: 20
Study 33135866 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic-supplemented arm
Number of subjects: 20
Study 33064621 — intervention group
Group type: EXPERIMENTAL
Intervention: Music-based approach to teach pursed-lip breathing; patients meet twice weekly for eight weeks for melodica instruction, group music-making, and COPD education.
Number of subjects: 0
Study 33064621 — intervention group
Group type: COMPARATOR
Intervention: Education-control group; details not specified.
Number of subjects: 0
Study 33064621 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group; details not specified.
Number of subjects: 0
Study 32892271 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Feedback (PFG)
Number of subjects: 130
Study 32892271 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert Feedback (EFG)
Number of subjects: 130
Study 32892271 — intervention group
Group type: COMPARATOR
Intervention: Video-Guided Learning (VLG)
Number of subjects: 130
Study 32329651 — intervention group
Group type: EXPERIMENTAL
Intervention: Larotrectinib
Number of subjects: 22
Study 32329651 — intervention group
Group type: EXPERIMENTAL
Intervention: Entrectinib
Number of subjects: 22
Study 33327246 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 82
Study 33327246 — intervention group
Group type: COMPARATOR
Intervention: Propofol (Control)
Number of subjects: 82
Study 33965574 — intervention group
Group type: EXPERIMENTAL
Intervention: Naldemedine
Number of subjects: 1095
Study 33965574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1095
Study 33542047 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (0.5 mg thrice daily for 5 days, then 0.5 mg twice daily for 5 days)
Number of subjects: 75
Study 33542047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 33542047 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 75
Study 34187296 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal NRS (based on greatest reduction in WOB)
Number of subjects: 30
Study 34187296 — intervention group
Group type: EXPERIMENTAL
Intervention: High flow nasal cannula (HFNC)
Number of subjects: 30
Study 34187296 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal continuous positive pressure (nCPAP)
Number of subjects: 30
Study 34187296 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen (O2)
Number of subjects: 30
Study 34187296 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard noninvasive parameters)
Number of subjects: 30
Study 32525048 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% atropine
Number of subjects: 383
Study 32525048 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025% atropine
Number of subjects: 383
Study 32525048 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine
Number of subjects: 383
Study 32525048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 383
Study 33453076 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D supplementation during pregnancy
Number of subjects: 0
Study 33453076 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 615916050 — intervention group
Group type: EXPERIMENTAL
Intervention: ETDRS PRP plus IVR (SS-PRP group)
Number of subjects: 40
Study 615916050 — intervention group
Group type: EXPERIMENTAL
Intervention: PASCAL PRP plus IVR (MS-PRP group)
Number of subjects: 40
Study 615916050 — intervention group
Group type: COMPARATOR
Intervention: Only IVR (IVR group)
Number of subjects: 40
Study 36047511 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium alginate 0.03 g per kg body weight per day
Number of subjects: 30
Study 36047511 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium alginate 0.06 g per kg body weight per day
Number of subjects: 30
Study 36047511 — intervention group
Group type: COMPARATOR
Intervention: Metformin 500 mg day‐1 for 60 days (positive control)
Number of subjects: 30
Study 36047511 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium alginate (both dosages)
Number of subjects: 30
Study 33576172 — intervention group
Group type: EXPERIMENTAL
Intervention: IVUS-guided PCI
Number of subjects: 809601
Study 33576172 — intervention group
Group type: COMPARATOR
Intervention: Standard PCI (Control)
Number of subjects: 809601
Study 34042773 — intervention group
Group type: EXPERIMENTAL
Intervention: HL7 FHIR standard implementation
Number of subjects: 0
Study 34042773 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32078063 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary iodine concentration (UIC) < 100 μg/L
Number of subjects: 75653
Study 32078063 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary iodine concentration (UIC) 100-199 μg/L
Number of subjects: 75653
Study 32078063 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary iodine concentration (UIC) 200-299 μg/L
Number of subjects: 75653
Study 32078063 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary iodine concentration (UIC) ≥ 300 μg/L
Number of subjects: 75653
Study 32078063 — intervention group
Group type: EXPERIMENTAL
Intervention: More than adequate iodine group
Number of subjects: 75653
Study 32078063 — intervention group
Group type: EXPERIMENTAL
Intervention: Excessive iodine group
Number of subjects: 75653
Study 32078063 — intervention group
Group type: COMPARATOR
Intervention: Adequate iodine (AI) group
Number of subjects: 75653
Study 33374017 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange (PLEX)
Number of subjects: 0
Study 33374017 — intervention group
Group type: COMPARATOR
Intervention: No plasma exchange (control group)
Number of subjects: 0
Study 34897950 — intervention group
Group type: EXPERIMENTAL
Intervention: Widespread pain
Number of subjects: 299
Study 34897950 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of painful sites
Number of subjects: 299
Study 35324220 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-affirmation intervention before viewing psychoeducation
Number of subjects: 172
Study 35324220 — intervention group
Group type: EXPERIMENTAL
Intervention: Single session of group counseling
Number of subjects: 172
Study 35324220 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation only (without self-affirmation)
Number of subjects: 172
Study 35324220 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition (no intervention)
Number of subjects: 172
Study 33167953 — intervention group
Group type: EXPERIMENTAL
Intervention: Popular real fit influencer
Number of subjects: 154
Study 33167953 — intervention group
Group type: COMPARATOR
Intervention: Fictitious fit influencer
Number of subjects: 154
Study 34985846 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS + active iTBS
Number of subjects: 30
Study 34985846 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS + sham iTBS
Number of subjects: 30
Study 34985846 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham tDCS + active iTBS
Number of subjects: 30
Study 34985846 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS + sham iTBS
Number of subjects: 30
Study 32937260 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal Imaginal Exposure (IE)
Number of subjects: 20
Study 32937260 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VRET)
Number of subjects: 20
Study 34525408 — intervention group
Group type: EXPERIMENTAL
Intervention: Registry use in RCTs
Number of subjects: 47
Study 35023349 — intervention group
Group type: EXPERIMENTAL
Intervention: Active low-level transcutaneous vagus nerve stimulation (tragus), 20 Hz, 1 mA below discomfort threshold, for 1 hour daily for 3 months.
Number of subjects: 52
Study 35023349 — intervention group
Group type: COMPARATOR
Intervention: Sham low-level transcutaneous vagus nerve stimulation (earlobe), 20 Hz, 1 mA below discomfort threshold, for 1 hour daily for 3 months.
Number of subjects: 52
Study 32080686 — intervention group
Group type: EXPERIMENTAL
Intervention: DentalVibe
Number of subjects: 60
Study 32080686 — intervention group
Group type: COMPARATOR
Intervention: Traditional injection (control)
Number of subjects: 60
Study 35505544 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-control study design
Number of subjects: 0
Study 616880400 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP-700 (0.25 mg/kg and 0.35 mg/kg)
Number of subjects: 60
Study 616880400 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP-700 (1.00 mg/kg)
Number of subjects: 60
Study 616880400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 616880400 — intervention group
Group type: EXPERIMENTAL
Intervention: ABP-700
Number of subjects: 60
Study 35089982 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue-blocking glasses
Number of subjects: 60
Study 35089982 — intervention group
Group type: COMPARATOR
Intervention: Partial blue-blocking glasses
Number of subjects: 60
Study 32356207 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily preventive zinc dispersible tablet (7 mg/d; PZ)
Number of subjects: 3407
Study 32356207 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily micronutrient powder (10 mg zinc/d; MNP)
Number of subjects: 3407
Study 32356207 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic zinc supplements for diarrhea treatment (20 mg/d for 10 days; TZ)
Number of subjects: 3407
Study 32356207 — intervention group
Group type: COMPARATOR
Intervention: Daily placebo powder (Control)
Number of subjects: 3407
Study 36293916 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching condition (SSC)
Number of subjects: 44
Study 36293916 — intervention group
Group type: COMPARATOR
Intervention: Control condition (CC, no warm-up)
Number of subjects: 44
Study 34541920 — intervention group
Group type: EXPERIMENTAL
Intervention: Andexanet alfa
Number of subjects: 32
Study 34541920 — intervention group
Group type: COMPARATOR
Intervention: 4-Factor Prothrombin Complex (4F-PCC)
Number of subjects: 32
Study 33988943 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 100
Study 33988943 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 100
Study 32487035 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab in combination with nivolumab and trastuzumab
Number of subjects: 0
Study 32487035 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX in combination with nivolumab and trastuzumab
Number of subjects: 0
Study 32487035 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab or FOLFOX with nivolumab and trastuzumab
Number of subjects: 0
Study 32487035 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood-based signatures (e.g. immune response or suppression of anti-HER2 resistance)
Number of subjects: 0
Study 35129875 — intervention group
Group type: EXPERIMENTAL
Intervention: Alexandrite 755-nm picosecond laser
Number of subjects: 30
Study 35129875 — intervention group
Group type: COMPARATOR
Intervention: KTP 532-nm picosecond laser
Number of subjects: 30
Study 35129875 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lasers
Number of subjects: 30
Study 34215339 — intervention group
Group type: EXPERIMENTAL
Intervention: FEIBA
Number of subjects: 12
Study 34215339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 36506251 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-clamp LPN
Number of subjects: 249
Study 36506251 — intervention group
Group type: COMPARATOR
Intervention: On-clamp LPN
Number of subjects: 249
Study 36506251 — intervention group
Group type: EXPERIMENTAL
Intervention: RENAL score increase
Number of subjects: 249
Study 36506251 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor size increase
Number of subjects: 249
Study 33370174 — intervention group
Group type: EXPERIMENTAL
Intervention: STEP‐KOA
Number of subjects: 345
Study 33370174 — intervention group
Group type: COMPARATOR
Intervention: Arthritis Education (AE)
Number of subjects: 345
Study 34798841 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Optic White (GO) toothpaste
Number of subjects: 45
Study 34798841 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Total Whitening (GT) toothpaste
Number of subjects: 45
Study 34798841 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (GC)
Number of subjects: 45
Study 34798841 — intervention group
Group type: EXPERIMENTAL
Intervention: Bencer (GB) toothpaste
Number of subjects: 45
Study 34798841 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfect White Black (GP) toothpaste
Number of subjects: 45
Study 35420662 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery (laparoscopic adjustable gastric banding)
Number of subjects: 82
Study 35420662 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 82
Study 35420662 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 82
Study 34461844 — intervention group
Group type: EXPERIMENTAL
Intervention: Postnatal care service utilization
Number of subjects: 600
Study 34461844 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother's and partner's secondary education level and above
Number of subjects: 600
Study 34461844 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner's occupation in civil service and business
Number of subjects: 600
Study 34461844 — intervention group
Group type: EXPERIMENTAL
Intervention: Household income of at least MK50,000
Number of subjects: 600
Study 34461844 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint decision making
Number of subjects: 600
Study 34461844 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of the available PNC services
Number of subjects: 600
Study 34461844 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of at least one postpartum danger sign
Number of subjects: 600
Study 34461844 — intervention group
Group type: EXPERIMENTAL
Intervention: Health facility delivery of last pregnancy
Number of subjects: 600
Study 32295491 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraosseous application of autologous mesenchymal stromal cells (MSCs) after core decompression (CD)
Number of subjects: 21
Study 32295491 — intervention group
Group type: COMPARATOR
Intervention: Core decompression (CD) only
Number of subjects: 21
Study 35549736 — intervention group
Group type: EXPERIMENTAL
Intervention: TTM-based mobile health application program
Number of subjects: 122
Study 32470434 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous haematopoietic stem‐cell transplantation
Number of subjects: 0
Study 32470434 — intervention group
Group type: COMPARATOR
Intervention: Bortezomib–melphalan–prednisone
Number of subjects: 0
Study 32470434 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib–lenalidomide–dexamethasone consolidation therapy
Number of subjects: 0
Study 32470434 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance
Number of subjects: 0
Study 36326863 — intervention group
Group type: EXPERIMENTAL
Intervention: MODSUG diet (50% carbohydrate [20% sugars], 15% protein, 35% fat)
Number of subjects: 25
Study 36326863 — intervention group
Group type: EXPERIMENTAL
Intervention: LOWSUG diet (50% carbohydrate [< 5% sugars], 15% protein, 35% fat)
Number of subjects: 25
Study 36326863 — intervention group
Group type: EXPERIMENTAL
Intervention: LOWCHO diet (8% carbohydrate [< 5% sugars], 15% protein, 77% fat)
Number of subjects: 25
Study 33593836 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime
Number of subjects: 7668
Study 33593836 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 7668
Study 33593836 — intervention group
Group type: COMPARATOR
Intervention: In-house mortality, colonization with resistant organisms, Clostridiodes difficile infection
Number of subjects: 7668
Study 33593836 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-pseudomonal antibiotics
Number of subjects: 7668
Study 32276603 — intervention group
Group type: EXPERIMENTAL
Intervention: SEIQoL-DW
Number of subjects: 99
Study 32276603 — intervention group
Group type: COMPARATOR
Intervention: SEIQoL-PF/G
Number of subjects: 99
Study 36058429 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab 10mg/kg plus standard therapy (oral glucocorticoids and either cyclophosphamide or mycophenolate mofetil)
Number of subjects: 142
Study 36058429 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus standard therapy (oral glucocorticoids and either cyclophosphamide or mycophenolate mofetil)
Number of subjects: 142
Study 32918332 — intervention group
Group type: EXPERIMENTAL
Intervention: Connective Tissue Grafting (CTG)
Number of subjects: 60
Study 32918332 — intervention group
Group type: COMPARATOR
Intervention: No Connective Tissue Grafting (Control)
Number of subjects: 60
Study 32013175 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid petroleum gas (LPG) cooking distributed to households for 3 months (3 cylinders)
Number of subjects: 0
Study 32013175 — intervention group
Group type: COMPARATOR
Intervention: Usual cooking methods (control group)
Number of subjects: 0
Study 36219446 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual material (4-minute video)
Number of subjects: 290
Study 36219446 — intervention group
Group type: COMPARATOR
Intervention: Paper-based material
Number of subjects: 290
Study 32914917 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology for falls prevention
Number of subjects: 0
Study 35996218 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally and linguistically appropriate self-management program for hearing loss
Number of subjects: 31
Study 35996218 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group discussions
Number of subjects: 31
Study 33793282 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 202
Study 33793282 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 202
Study 33793282 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) - Change Talk (CT)
Number of subjects: 202
Study 33793282 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE) - Learning Talk (LT)
Number of subjects: 202
Study 34984808 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide
Number of subjects: 9543
Study 34984808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9543
Study 34110925 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved field radiation therapy (IFRT) in Sonic Hedgehog MB patients
Number of subjects: 549
Study 34110925 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose craniospinal irradiation (LDCSI) in group 4 MB patients
Number of subjects: 549
Study 32541174 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanoliposomal irinotecan plus fluorouracil and folinic acid (nal-IRI + FF)
Number of subjects: 0
Study 32541174 — intervention group
Group type: COMPARATOR
Intervention: Fluorouracil and folinic acid (FF) alone
Number of subjects: 0
Study 35585696 — intervention group
Group type: EXPERIMENTAL
Intervention: Baloxavir marboxil (high exposure: AUC0-inf 5.13-16.65 μg.hr/mL)
Number of subjects: 1781
Study 35585696 — intervention group
Group type: EXPERIMENTAL
Intervention: Baloxavir marboxil (low exposure: AUC0-inf 0.72-5.13 μg.hr/mL)
Number of subjects: 1781
Study 32275771 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin 10 mg/day (weak induction)
Number of subjects: 12
Study 32275771 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin 600 mg/day (strong induction)
Number of subjects: 12
Study 35839116 — intervention group
Group type: EXPERIMENTAL
Intervention: HFMEA-based predictive care combined with multimodal analgesia
Number of subjects: 150
Study 35839116 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing combined with multimodal analgesia
Number of subjects: 150
Study 34615781 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed orthodontic appliance
Number of subjects: 110
Study 34615781 — intervention group
Group type: COMPARATOR
Intervention: Clear aligners
Number of subjects: 110
Study 32213783 — intervention group
Group type: EXPERIMENTAL
Intervention: VL25 (25% velocity loss)
Number of subjects: 29
Study 32213783 — intervention group
Group type: COMPARATOR
Intervention: VL50 (50% velocity loss)
Number of subjects: 29
Study 34862162 — intervention group
Group type: EXPERIMENTAL
Intervention: Training session on six communication strategies
Number of subjects: 130
Study 34862162 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 130
Study 32604939 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy sessions based on connective tissue massage
Number of subjects: 24
Study 32604939 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (ultrasound sessions without conductive gel and machine turned off)
Number of subjects: 24
Study 32604939 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 24
Study 35089910 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD severity
Number of subjects: 184
Study 35089910 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms severity
Number of subjects: 184
Study 33558661 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice weekly supervised impact loading and resistance exercise (ImpRes)
Number of subjects: 135
Study 33558661 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised aerobic and resistance exercise (AerRes)
Number of subjects: 135
Study 33558661 — intervention group
Group type: COMPARATOR
Intervention: Usual care/delayed supervised aerobic exercise (DelAer)
Number of subjects: 135
Study 34129271 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice a week range of motion (ROM) exercise over a 4 weeks period
Number of subjects: 48